MIRA INFORM REPORT

 

 

Report Date :

14.04.2014

 

IDENTIFICATION DETAILS

 

Name :

CRESCENT THERAPEUTICS LIMITED

 

 

Formerly Known As :

CRESCENT THERAPEUTICS PRIVATE LIMITED

 

 

Registered Office :

H. No 4-7-11/4/B, Crescent Towers, Raghavendra Nagar, Nacharam, Hyderabad – 500076, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

21.11.2000

 

 

Com. Reg. No.:

10-035708

 

 

Capital Investment / Paid-up Capital :

Rs.40.000 Millions

 

 

CIN No.:

[Company Identification No.]

U29297AP2000PLC035708

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

HYDC01209F

 

 

PAN No.:

[Permanent Account No.]

AABCC9421B

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of pharmaceutical products, pharmaceuticals formulations, mask, disposable items.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (46)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 471000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record.

 

Company has performed well. Overall financial position of the company is decent.

 

Trade relations are reported to be fair. Business is active. Payments are reported to be usually correct.

 

The company can be considered for business dealing at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 1, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

India’s current account deficit for the fiscal third quarter ended September 2013 narrowed to $4.2 billion or 0.9 % of the gross domestic product from $31.9 billion or 6.5 % of GDP a year earlier, thanks to a pick-up in exports and moderation in gold imports. Manufacturing activity and new orders in India showed their strongest growth in a year in February. The news comes as a relief after data showed Asia’s third largest economy grew by a slower-than-expected 4.7 % annually in the three months through December. The HSBC Manufacturing Purchasing Managers’ Index which gauges the business activity of India’s factories but not its’ utilities, rose to 52.5 in February, its highest in a year from 51.4 in January. Overall new orders for factory goods which rose to a one-year high of 54.9 contributed to the surge. China has emerged as India’s biggest trading partner in the current financial year replacing the United Arab Emirates and pushing it to the third spot. India-China trade has reached $49.5 billion with a 8.7 % share in India’s total trade. The US comes second at $46 billion with 8.1 % share during the first nine months of the current financial year.

 

The Reserve Bank of India has granted an additional nine months to the public to exchange currency notes printed before 2005 including Rs 500 and Rs 1,000 denominations, pushing the deadline to January 1, 2015. A day before dates for the Lok Sabha polls were announced, the government decided to hike interest rates on fixed deposit schemes offered by post offices up to 0.2 per cent. The new rates will be effective April, 1. The Supreme Court will resume hearing on March, 11 Nokia’s appeal against a ruling over transferring ownership of its local mobile phones plant which is the subject of a tax dispute to Microsoft Corp.

 

In the last days of the current Government, another scam has surfaced. The defence ministry has ordered a probe into Hindustan Aeronautics Limited’s contracts from Britain’s Rolls-Royce Holdings worth at least $ 1.2 billion. The Central Bureau of Investigation will look into allegations that over $80 million was paid in kickbacks in a deal signed in 2011. India has asked Boeing Co. to find a solution for problems with state-owned Air India’s 787 Dreamliners. The aircraft has experienced a series of malfunctions since its debut in 2011.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION DENIED BY

 

Name :

Mr. Subhash

Designation :

Vice President

Contact No.:

91-40-27178843

Date :

10.04.2014

 

 

LOCATIONS

 

Registered Office :

H. No 4-7-11/4/B, Crescent Towers, Raghavendra Nagar, Nacharam, Hyderabad – 500076, Andhra Pradesh, India

Tel. No.:

91-40-27178843/ 27170830/ 27171067

Fax No.:

91-40-27176442

E-Mail :

skjctl@yahoo.co.in

vpca@crescenttherapeutics.org

finance@crescenttherapeutics.org

Website :

http://www.crescenttherapeutics.org

 

 

Factory :

Khasara No 587/588, Villagae Khunjal, Jharmajri, Baddi, Nalagarh District Solan – 173205, Himachal Pradesh, India

Tel. No.:

91-1795-271246

 

 

DIRECTORS

 

As on: 30.09.2014

 

Name :

Mr. Shaik Janimiya

Designation :

Managing Director

Address :

H. No: 4-10-119/S-1, HMT Nagar, Street No:11, Nacharam, Hyderabad – 500076, Andhra Pradesh, India 

Date of Birth/Age :

31.08.1957

Date of Appointment :

08.03.2007

DIN No.:

01089672

 

 

Name :                                

Shaik Thahera

Designation :

Director

Address :

H. No: 4-10-119/S-1, HMT Nagar, Street No:11, Nacharam, Hyderabad – 500076, Andhra Pradesh, India 

Date of Birth/Age :

18.05.1969

Date of Appointment :

21.11.2000

DIN No.:

01089807

 

 

Name :

Yeluripati Venkata Vijaya Bhaskara Ramabhadra Chainulu

Designation :

Additional Director

Address :                            

1-10-25,  Block No 95, St No 3, Ashoknagar, Hyderabad - 500020, Andhra Pradesh, India 

Date of Birth/Age :

01.11.1941

Date of Appointment :

25.01.2007

DIN No.:

02611623

 

 

Name :

Karakavenkata Venugopalakrishna Rao

Designation :

Additional Director

Address :

23-195, NUZVID, Krishna – 521201, Andhra Pradesh, India 

Date of Birth/Age :

01.06.1963

Date of Appointment :

25.01.2007

DIN No.:

02611732

 

 

KEY EXECUTIVES

 

Name :

Mr. Subhash

Designation :

Vice President

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 30.09.2014

 

Names of Shareholders

 

No. of Shares

SK. Janimiya

 

3080000

SK. Thahera

 

680000

Y.R. Chainulu

 

12305

K.V.V.G. Krishna Rao

 

100

SK. Javeed

 

227395

A. Parameshwar Rao

 

100

MD. Moinuddin

 

100

 

 

 

Total

 

4000000

 

Equity Share Break up (Percentage of Total Equity)

 

As on: 30.09.2014

 

Category

 

Percentage

Directors or relatives of directors

 

99.68

Other top fifty shareholders

 

0.32

 

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of pharmaceutical products, pharmaceuticals formulations, mask, disposable items.

 

 

GENERAL INFORMATION

 

Customers :

  • Ajantha Pharma Limited
  • Aarti Drugs Limited
  • Biotavia Pharma Limited
  • Cadila Pharmaceutical Limited
  • Cipla Limited
  • Elder Pharma Limited
  • Ferring Pharmaceutical Limited
  • Intas Pharmaceutical Limited
  • Mankind Pharma Limited
  • Panacea Biotech Limited
  • Wanbury Pharma Limited

 

 

No. of Employees :

Not Available

 

 

Bankers :

  • Canara Bank, MID Corporate Branch, SCO 12, Sector 10, Panchkula - 134109, Haryana, India
  • Andhra Bank, SME Mallapur, Mallapur, Hyderabad - 500076, Andhra Pradesh, India

 

 

Facilities :

(Rs. In Millions)

Secured Loan

As on

31.03.2013

As on

31.03.2012

LONG TERM BORROWING

 

 

Term Loan

 

 

Canara Bank

17.697

30.150

SHORT TERM BORROWING

 

 

Cash Credit

(Cash credit facilities secured by way of hypothecation of stocks and book debts of the company)

49.496

42.962

 

 

 

Total

67.193

73.112

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Ashwani K Gupta and Associates

Chartered Accountants

Address :

1105, Sector 21 B, Chandigarh – 160022, India

Mobile No.:

91-9888398905

PAN No.:

AACFA3955A

 

 

CAPITAL STRUCTURE

 

As on: 30.09.2013

 

Authorised Capital : Rs.45.000 Millions

 

Issued, Subscribed & Paid-up Capital : Rs.40.000 Millions

 

 

As on: 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4000000

Equity Shares

Rs.10/- each

Rs.40.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4000000

Equity Shares

Rs.10/- each

Rs.40.000 Millions

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

31.03.2013

31.03.2012

31.03.2011

 

 

 

 

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

40.000

40.000

40.000

(b) Reserves & Surplus

65.726

53.749

44.326

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

12.154

0.000

0.000

Total Shareholders’ Funds (1) + (2)

117.880

93.749

84.326

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

39.744

55.149

107.354

(b) Deferred tax liabilities (Net)

9.553

8.101

6.468

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

49.297

63.250

113.822

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

49.496

42.962

69.015

(b) Trade payables

37.972

17.406

56.168

(c) Other current liabilities

22.912

34.015

21.504

(d) Short-term provisions

3.358

2.516

3.666

Total Current Liabilities (4)

113.738

96.899

150.353

 

 

 

 

TOTAL

280.915

253.898

348.501

 

 

 

 

II.          ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

142.925

140.872

162.228

(ii) Intangible Assets

1.200

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

144.125

140.872

162.228

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

61.817

46.051

75.083

(c) Trade receivables

53.932

44.244

83.182

(d) Cash and cash equivalents

0.291

0.176

0.193

(e) Short-term loans and advances

2.707

2.511

2.602

(f) Other current assets

18.043

20.044

25.213

Total Current Assets

136.790

113.026

186.273

 

 

 

 

TOTAL

280.915

253.898

348.501

 


 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

Income

301.303

252.935

233.732

 

Other Income

2.843

0.400

0.000

 

TOTAL                                                                 (A)

304.146

253.335

233.732

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

210.214

146.850

97.417

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

2.558

21.080

-13.875

 

Employees benefits expense

18.812

17.494

38.053

 

Other expenses

34.170

29.941

76.399

 

Prior period expense

0.000

0.195

0.583

 

TOTAL                                                                 (B)

265.754

215.560

198.577

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION            (C)

38.392

37.775

35.155

 

 

 

 

 

Less

FINANCIAL EXPENSES                                     (D)

14.364

17.022

17.577

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                              (E)

24.028

20.753

17.578

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    (F)

7.242

7.180

7.955

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX (E-F)               (G)

16.786

13.573

9.623

 

 

 

 

 

Less

TAX                                                                      (H)

4.809

4.150

5.829

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX  (G-H)                  (I)

11.977

9.423

3.794

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

11.977

9.423

3.794

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

2.99 

NA

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

3.94

3.72

1.62

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

5.57

5.37

4.12

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

5.98

5.35

2.76

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.14

0.14

0.11

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.76

1.05

2.09

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.20

1.17

1.24

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

40.000

40.000

40.000

Reserves & Surplus

44.326

53.749

65.726

Net worth

84.326

93.749

105.726

 

 

 

 

long-term borrowings

107.354

55.149

39.744

Short term borrowings

69.015

42.962

49.496

Total borrowings

176.369

98.111

89.240

Debt/Equity ratio

2.092

1.047

0.844

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

233.732

252.935

301.303

 

 

8.216

19.123

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

233.732

252.935

301.303

Profit

3.794

9.423

11.977

 

1.62%

3.73%

3.98%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

Yes

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

UNSECURED LOAN

(Rs. In Millions)

Particular

As on

31.03.2013

As on

31.03.2012

LONG TERM BORROWING

 

 

Loans and Advance from related parties 

0.000

13.489

Other loans and advance

 

 

Vehicle Loans

2.939

1.479

Other loans

19.108

10.031

 

 

 

Total

22.047

24.999

 

 

OPERATION

 

The sales during the year have increased from Rs.253.335 Millions in 201 1-12 to Rs. 304.146 Millions in 2012-13, registering a growth of about 20.06% and the net profit after tax has increased from 96.17 lacs to Rs 11.977 Millions. The reason for the increased net profit was due to growth in Sales, Decrease in finance charges and other expenses.

 

The timely effort put by the Crescent team has helped the Company to reach good number of manufacturer and could enter in to manufacturing agreements with a few Companies. The major achievement was M/S Aarti Drugs Limited from which the turnover and contribution was more than the previous year.

 

 

INDUSTRIAL SCENARIO

 

The Indian Pharmaceutical Industry is the third largest in the world and is growing at about 8% annually and is expected to touch USD 20 billion by 2015.The present domestic market is controlled to the extent of about 70% by top 250 companies and the units in SME sector have to withstand the fierce competition and raise to the level of feasible turnover. These units need to improve the expertise to meet the challenges of technological developments by suitable training and have adequate finance for technological up-gradation and adoption of good manufacturing practices (GMP) to meet global quality standards.

 

 

FUTURE OUTLOOK

 

The Company with its world class and GMP compliant manufacturing facilities, qualified and experienced team of professionals, continued enquiries from leading domestic Companies for using the infrastructure hopes to improve its turnover in the coming years to the satisfaction of all stakeholders. The Company is aiming to capture the overseas market in third world countries and product registration with several countries like Sri Lanka. Vietnam, Myanmar is under process. The Company is in touch with the prospective buyers from these countries.

 

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10304578

30/08/2011

3,000,000.00

DIRECTOR OF INDUSTRIES HIMACHAL PRADESH

THROUGH DY. DIRECTOR OF INDUSTRIES, SINGLE WINDOW CLEARANCE AGENCY (SWCA), BADDI, HIMACHAL PRADESH - 174103, INDIA

B19774975

2

10289711

01/01/2014 *

174,000,000.00

CANARA BANK

MID CORPORATE BRANCH SCO 12, SECTOR 10, PANCHKULA, HARYANA - 134109, INDIA

B93975894

3

90121810

15/06/2004

559,565.00

ICICI BANK LIMITED

ICICI TOWERS BANDRA KURLA COMPLEX, MUMBAI, MAHARASHTRA, INDIA

-

 

* Date of charge modification

 

 

FIXED ASSETS:

 

Tangible Assets

  • Land
  • Building
  • Plant and Machinery
  • Laboratory Equipment
  • Office Equipments
  •  Furniture and Fixtures
  • Vehicle

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.27

UK Pound

1

Rs.101.10

Euro

1

Rs.83.74

 

 

INFORMATION DETAILS

 

Information Gathered by :

SUV

 

 

Analysis Done by :

SUM

 

 

Report Prepared by :

VRN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.